Bentley Pharmaceuticals (BNT) Q3 2025 Earnings

Screener

Reported November 13, 2025 · Before market open

Revenue$3.1B

EPS$0.06

Next report

Aug 13, 2026 (In 1 week)

Versus estimates

Revenue

Q3 2025$3.1B

Q2 2025$3.0B Q1 2025$2.4B Q4 2024$6.0B

Diluted EPS

Q1 2026$0.07 Q4 2025$0.06

Q3 2025$0.06

Q2 2025$0.06 Q1 2025$0.09 Q4 2024$0.08

FAQ

When did Bentley Pharmaceuticals report Q3 2025 earnings?: Bentley Pharmaceuticals (BNT) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Bentley Pharmaceuticals's Q3 2025 revenue and EPS?: Bentley Pharmaceuticals reported revenue of $3.1B and eps of $0.06 for Q3 2025.
How did Bentley Pharmaceuticals's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 4.8% from $3.0B a year earlier and eps declined 25.0% from $0.08.

Ask the moment Bentley Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk